NDC 72626-2701 – Sofosbuvir and Velpatasvir
Velpatasvir 100 mg/1; Sofosbuvir 400 mg/1 · Tablet, Film Coated · Oral
Product NDC72626-2701
Product details
- Brand name
- Sofosbuvir and Velpatasvir
- Generic name
- Velpatasvir and Sofosbuvir
- Labeler
- Asegua Therapeutics LLC
- Dosage form
- Tablet, Film Coated
- Route
- Oral
- Marketing category
- NDA AUTHORIZED GENERIC · NDA208341
- Marketed since
- November 14, 2018
- Listing expires
- December 31, 2026
- Pharmacologic class
- Hepatitis C Virus NS5A Inhibitor; Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor
Active ingredients
- Velpatasvir 100 mg/1
- Sofosbuvir 400 mg/1
Uses, dosage, side effects and warnings for Sofosbuvir and Velpatasvir →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 72626-2701-1 | 2 BLISTER PACK in 1 CARTON (72626-2701-1) / 14 TABLET, FILM COATED in 1 BLISTER PACK | Nov 14, 2018 |
Recalls mentioning this NDC
- D-0313-2025 Apr 16, 2025 · Class II
Defective Container: blister packs not properly sealed resulting in tablets being loose in the carton.